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Introduction
Cardiac morphogenesis understandably relies on genes that
function within the heart, but many genes extrinsic to the heart
also affect its development. Genes required to establish the left-
right axis of the embryo indirectly affect heart morphogenesis.
They do this by ultimately affecting the expression of the Pitx2
gene (Burdine and Schier, 2000; Franco and Campione, 2003;
Hamada et al., 2002). It is the Pitx2c isoform that is central to
the establishment of laterality; it is expressed in left lateral
plate mesoderm (LPM), and later expression in the left side of
the heart is considered to extend from this (Campione et al.,
2001). Pitx2c is a Nodal-responsive gene and thus its
expression in the left LPM occurs as a direct consequence of
Nodal signaling in the tissue. Nodal expression in the left LPM,
establishes the left side of the embryo, and so genes required
to initiate, maintain and restrict the expression of Nodal are all
required for correct Pitx2c expression.
The Cited2 gene affects cardiac morphogenesis and was
identified from studies of differential gene expression in the
early embryo (Dunwoodie et al., 1998), cytokine function (Sun
et al., 1998) and transcriptional regulation during hypoxia
(Bhattacharya et al., 1999). Cited2 expression is widespread
during early mouse and chicken development (Dunwoodie et
al., 1998; Schlange et al., 2000). Furthermore, expression of
Cited2 can be activated by factors, including low oxygen
tension, cytokines, lipopolysacharide and shear stress
(Bhattacharya et al., 1999; Sun et al., 1998; Yokota et al.,
Establishment of the left-right axis is a fundamental
process of vertebrate embryogenesis. Failure to develop
left-right asymmetry leads to incorrect positioning and
morphogenesis of numerous internal organs, and is
proposed to underlie the etiology of several common
cardiac malformations. The transcriptional modulator
Cited2 is essential for embryonic development: Cited2-null
embryos die during gestation with profound developmental
abnormalities, including cardiac malformations,
exencephaly and adrenal agenesis. Cited2 is also required
for normal establishment of the left-right axis; we
demonstrate that abnormal heart looping and right atrial
and pulmonary isomerism are consistent features of the
left-right-patterning defect. We show by gene expression
analysis that Cited2 acts upstream of Nodal, Lefty2 and
Pitx2 in the lateral mesoderm, and of Lefty1 in the
presumptive floor plate.
Although abnormal left-right patterning has a major
impact on the cardiac phenotype in Cited2-null embryos,
laterality defects are only observed in a proportion of these
embryos. We have therefore used a combination of high-
resolution imaging and three-dimensional (3D) modeling to
systematically document the full spectrum of Cited2-
associated cardiac defects. Previous studies have focused on
the role of Cited2 in cardiac neural crest cell development,
as Cited2 can bind the transcription factor Tfap2, and thus
affect the expression of Erbb3 in neural crest cells.
However, we have identified Cited2-associated cardiac
defects that cannot be explained by laterality or neural
crest abnormalities. In particular, muscular ventricular
septal defects and reduced cell density in the
atrioventricular (AV) endocardial cushions are evident in
Cited2-null embryos. As we found that Cited2 expression
tightly correlated with these sites, we believe that Cited2
plays a direct role in development of the AV canal and
cardiac septa. We therefore propose that, in addition to the
previously described reduction of cardiac neural crest cells,
two other distinct mechanisms contribute to the spectrum
of complex cardiac defects in Cited2-null mice; disruption
of normal left-right patterning and direct loss of Cited2
expression in cardiac tissues.
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2003). This may account for the complexity of expression in
developing embryos.
Cited2 interacts with CBP and p300 – homologous proteins
with intrinsic acetyltransferase and E4 ubiquitin ligase
activities (Chan and La Thangue, 2001; Grossman et al., 2003).
It inhibits the transcriptional activity of Hif1α, through
competition for overlapping binding sites on CBP/p300 (De
Guzman et al., 2004; Freedman et al., 2003). This may
represent a paradigm for Cited2 function, as it also appears to
displace Ets1 from CBP/p300 (Yokota et al., 2003). In addition,
Cited2 interacts directly with the transcription factors Lhx2 and
Tfap2 (Bamforth et al., 2001; Glenn and Maurer, 1999).
Cited2-null embryos display numerous developmental
defects (Bamforth et al., 2001; Martinez Barbera et al., 2002;
Yin et al., 2002). Cardiac defects previously reported in Cited2-
null embryos include: double outlet right ventricle (DORV);
atrial septal defect (ASD); ventricular septal defect (VSD);
overriding aorta; persistent truncus arteriosus (PTA); and
pulmonary artery stenosis. Previously, these defects had only
been considered in light of Tfap2 and Hif1α, and were only
described at late stages of gestation (13.5 dpc onwards) when
the heart has essentially reached its final morphology
(Bamforth et al., 2001; Martinez Barbera et al., 2002; Yin et
al., 2002). We determined the developmental origins of the
cardiac defects by examining cardiac morphogenesis in detail
at a number of embryonic stages, and determined the
expression pattern of Cited2 in relation to heart development.
We observed that the heart loops abnormally in a proportion
of Cited2-null embryos, and that these embryos have right
atrial isomerism (RAI). In these embryos, Nodal, Lefty2 and
Pitx2c are not expressed in lateral mesoderm, and Lefty1
expression in the prospective floor plate (PFP) is abnormal.
This shows that abnormal left-right patterning has a major
impact on the cardiac phenotype in Cited2-null embryos. In
addition, we performed a detailed analysis of the endpoint
cardiac phenotypes using episcopic fluorescence image
capturing (EFIC) and three-dimensional (3D) modeling. A
number of abnormalities were identified in Cited2-null
embryos that lacked a laterality defect, and some of these were
consistent with a reduction in cardiac neural crest (CNC) cells.
There were, however, two defects that did not seem to relate
to abnormalities in laterality or CNC cells: reduced cell density
in the AV endocardial cushions and muscular ventricular septal
defects (VSD). These defects did, however, directly correlate
with Cited2 expression and this suggests that Cited2 also plays
a direct role in cardiac tissue.
In summary, we demonstrate that Cited2-null embryos
display a spectrum of cardiovascular defects: some consistent
with a laterality defect, others with a reduction in neural crest
cells and yet others concordant with Cited2 acting directly
within cardiac tissue to affect morphogenesis.
Materials and methods
Mouse lines and genotyping
The Cited2-lacZ mouse line (Barbera et al., 2002) is maintained on a
C57BL/6;129 hybrid genetic background following three backcrosses
onto C57BL/6. Mice heterozygous for this Cited2 targeted allele
(Cited2+/–) were intercrossed to produce Cited2 wild-type (Cited2+/+),
heterozygous (Cited2+/–) and homozygous null (Cited2–/–) embryos
for analysis. Cited2 heterozygous mice were also crossed with mice
homozygous for the MLC3F-nlacZ-2E transgene, which is maintained
on a SJL;C57BL/6 hybrid genetic background (Kelly et al., 1995).
Morphology, histology, RNA in situ hybridization and X-gal
staining
EFIC was used for high resolution morphological studies (Weninger
and Mohun, 2002). Histology, RNA in situ hybridization and X-gal
staining were performed as described (Kaufman, 1992; Hogan et al.,
1994; Harrison et al., 1995). cDNA probe details are as follows:
Cited2 (Dunwoodie et al., 1998); Nodal, Lefty1/2 and Pitx2c probes
were a gift from Christine Biben and Richard Harvey.
Determination of cell density in endocardial cushions
Cell density of the AV cushions was measured in three Cited2 wild-
type and three Cited2-null embryos at 10.5 dpc. Wax sections of each
embryo were cut at a 45° angle (midway between frontal and
transverse) and every section collected. The number of cells in the
central section plus two before and two after the central section were
counted. Cushion area was measured using Image J software v1.24o
(NIH), and the results expressed as density of cells per µm2 cushion.
Cell density was compared using analysis of variance.
Scanning electron microscopy (SEM)
Following incubation in Karnovsky’s fixative (2% paraformaldehyde,
2.5% glutaraldehyde and 0.1 M sodium phosphate buffer at pH 7.2),
SEM was performed (Webb et al., 1998).
Results
Cited2 is expressed in the heart and elsewhere in
the embryo
The cardiovascular defects previously identified in Cited2-null
embryos have been ascribed to a reduction in CNC cells or
impaired Hif1α activity (Bamforth et al., 2001; Martinez
Barbera et al., 2002; Yin et al., 2002). Cited2 was expressed in
a number of sites within the embryo that could impact on the
development of the heart (Fig. 1). Cited2 at 7.5 dpc was
expressed in the ventral node, predominantly in the caudal lip
but also in the depression of the node (Fig. 1A-C) (Dunwoodie
et al., 1998). Expression was readily detected in 8 dpc embryos
in the cardiac crescent, anterior lateral mesoderm and in trunk
paraxial mesoderm (Fig. 1C-F). At 9.25 dpc, expression was
elevated in dorsal neuroectoderm at the forebrain-midbrain
boundary, and in the hindbrain (Fig. 1G,H). Expression was
also readily detected in branchial arches 1 to 3, and in somites.
At this stage, in the heart, Cited2 expression was widespread:
elevated levels of expression were identified in the aortic sac,
in the myocardium adjacent to the endocardial cushions of the
outflow tract and the AV canal, and in the presumptive atria
and sinus venosus (Fig. 1G,I-K). At 10.5 dpc, elevated Cited2
expression was detected in branchial arch 4, the outflow tract
and the AV canal (Fig. 1L-N). At 13.5 dpc Cited2 expression
was largely restricted to the outflow and inflow regions of the
heart, AV cushion, septum primum and the tip of the muscular
ventricular septum (Fig. 1O-Q). With respect to expression in
the heart, Cited2 is found predominantly in the myocardium;
however, some endocardial cells, and cells within the
endocardial cushion, also express the gene.
Abnormal heart looping and atrial isomerism are
features of the Cited2 null phenotype
Cited2-null embryos die from 14.5 dpc (Table 1). Examination
of Cited2-null hearts between 9.5 and 12.5 dpc, revealed that
Development 132 (6) Research article
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Fig. 1. Cited2 is differentially
expressed in the heart and
elsewhere during
development. (A) Anterior
view of a late headfold stage
embryo (7.5 dpc) showing
expression in the ventral node
(arrow), cardiac crescent and
blood islands. (B) Ventral
view of a flatmounted four-
somite stage embryo (8 dpc)
showing expression in the
cardiac crescent and in the
caudal lip and pit of the node
(arrow). (C) Ventral view of a
flatmounted six-somite stage
embryo (8 dpc) showing
expression in the cardiac
crescent, anterior lateral
mesoderm (black arrow),
paraxial mesoderm (white
arrow) and node. (D) Anterior
view of a six-somite stage
embryo showing elevated
expression in the cardiac
crescent, anterior lateral
mesoderm and trunk paraxial
mesoderm. (E,F) Transverse
sections through D at the
levels indicated showing
elevated expression in the
cardiac mesoderm (arrow) and
low-level expression
throughout. (G) Lateral and
dorsal view of 21-somite
stage embryo (9.5 dpc)
showing elevated expression
in the forebrain-midbrain
boundary, branchial arches 1
and 2, heart, and somites. (H)
Dorsal view of the embryo in
G showing expression in the
hindbrain (rhombomeres 3, 5,
6, 7) and adjacent paraxial
mesoderm. (I-K) Frontal
sections through a 21-somite
stage embryo at the levels
indicated in G. (I) Expression
is elevated in the ventricular
myocardium and trabeculae of
the outflow tract and
presumptive right ventricle;
(J) in the myocardium and, to
a lesser extent, the
endocardium and endocardial cushion cells in the outflow tract and atrioventricular canal; and (K) in the aortic sac, presumptive atria and
sinus venosus (inflow tract). (L) Lateral view of 40-somite stage embryo (10.5 dpc) showing expression in the outflow tract, atrioventricular
canal (black arrow), branchial arch 4 (white arrow), central nervous system, somites and limbs. (M,N) Sections through a 40-somite stage
embryo at the levels indicated in L, showing: expression in the (M) outflow tract and, to a lesser extent, in the compact myocardium and
trabeculae of the ventricles; and expression in the (N) myocardium adjacent to the endocardial cushion of the atrioventricular canal.
(O) Ventral and (P) dorsal views of a heart dissected from an embryo at 13.5 dpc showing expression predominantly in the outflow tract (O)
and inflow region (P). (Q) Frontal section through a dissected heart at the same stage as shown in O,P showing expression in the septum
primum (black arrow), around the vena cava (asterisk) and in the endocardial cushions of the atrioventricular canal (white arrow). Cited2
expression was assayed by detecting β-galactosidase activity from the Cited2-lacZ allele in embryos heterozygous (A,B,G,H,L,O,P) or
homozygous (I,J,K,M,N,Q) for the allele, or via Cited2 RNA hybridization (C-F). The colorimetric reaction used to identify Cited2 transcripts
was extended for the embryo in D, in order to reveal low levels of Cited2 expression. cc, cardiac crescent; oft, outflow tract; ift, inflow tract;
v, ventricle; avc, atrioventricular canal; as, aortic sac. Scale bar: 135 µm in A,B; 260 µm in C,D,H; 35 µm in E,F; 280 µm in G; 50 µm in I-K;
550 µm L; 94 µm in M,N; 390 µm O,P; 310 µm Q.
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looping was abnormal (Fig. 2). All Cited2 wild-type (n=167)
and heterozygous (n=203) embryos had normal rightward (D)
looping hearts (Fig. 2A). By contrast, almost half (52/115) of
all Cited2-null embryos showed abnormalities in heart looping
(Fig. 2B,C): 12 had abnormal D-looped hearts, while 40 had
leftward (L) looped hearts. In most L-looped hearts, the
ventricles were positioned on the left side of the midline of the
embryo, while in abnormal D-looped hearts, both ventricles
were on the right side of the midline. These looping defects
indicated that specification of the left-right axis might
not have occurred correctly in the Cited2-null
embryos. To address this, we used the MLC3F-
enhancer transgene that marks the right atrium
(Franco et al., 2001; Kelly et al., 1998). At 10.5 dpc,
all Cited2 wild-type (n=69; Fig. 2D) and
heterozygous embryos (n=61; data not shown)
showed characteristic transgene expression in the
right atrium, as did Cited2-null embryos with
correctly looped hearts (n=13; Fig. 2E). By contrast,
RAI, detected by bilateral expression of the MLC3F-
enhancer transgene, was apparent in all Cited2-null
embryos with an abnormally looped heart (n=15 for
abnormal L-loops and n=6 for abnormal D-loops; Fig.
2F). These results demonstrate that the cardiac
looping defects prevalent in Cited2-null embryos are
concordant with RAI. In all Cited2 null-embryos with
RAI (n=14), we found right pulmonary isomerism
(RPI): four lung lobes on both sides, as apposed to
the normal arrangement with one lung lobe on the left
and four on the right. In contrast to the thoracic
isomerism, there was incomplete penetrance of
abdominal isomerism: the stomach instead of lying
normally on the left, was in the midline or on the right
hand side (n=8/14).
Determinants of laterality are abnormally
expressed in a proportion of Cited2-null
embryos
In order to examine the relationship of Cited2 with
other genes involved in specifying left-right identity,
we examined Nodal expression. Nodal was
asymmetrically expressed in the left LPM in Cited2 wild-type
(n=6) and heterozygous (n=12) embryos, and bilaterally
expressed within the node (Fig. 3A,B). By contrast, two out of
six Cited2-null embryos lacked Nodal expression in the left
LPM (Fig. 3C). However, Nodal expression within the node
was comparable with that in the controls. This suggests that
Cited2 is required for initiation or maintenance of Nodal
expression in the LPM, but not within the node.
Lefty1 and Lefty2 interact with Nodal and its co-receptors
(cripto and cryptic) to block Nodal signaling (Chen and Shen,
2004; Cheng et al., 2004; Hamada et al., 2002). Lefty2 is
expressed in the left LPM and is a direct target of Nodal (Meno
et al., 1997; Meno et al., 1996; Saijoh et al., 1999; Saijoh et
al., 2000). Lefty1 is expressed in the left side of the PFP but,
unlike Nodal, Lefty2 and Pitx2c, its expression is independent
of Foxh1. Despite this, the reliance of Lefty1 expression on
Cryptic suggests that Nodal and/or Gdf1 are important for
Lefty1 expression (Hamada et al., 2002; Yan et al., 1999). As
loss of Nodal expression in the LPM is a feature of the Cited2-
null phenotype, we would expect a proportion of Cited2-null
embryos to lack Lefty1 and Lefty2 expression. Lefty1 and
Lefty2 were expressed normally in Cited2 wild-type (n=13),
heterozygous (n=17) and some Cited2-null (n=5) embryos
(Fig. 3D,E,G,H). However, a proportion of Cited2-null
embryos (n=4) lacked Lefty2, and expression of Lefty1 was
limited to and maintained in the posterior PFP (Fig. 3F,I).
Expression of Shh is normal in the midline of all Cited2-null
embryos, precluding the possibility that the embryonic midline
is compromised (data not shown). Persistent posterior
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Fig. 2. Cited2-null hearts display cardiac looping defects and atrial isomerism.
(A-C) Scanning electron micrographs showing ventral views of hearts at 9.5 dpc
(23 somites). The head, tail and the pericardium were removed. (A) Cited2 wild-
type heart showing a normal D (rightward) loop. (B) Cited2-null heart showing
an abnormal D loop. The left ventricle is ventrally displaced and occupies a more
central position than normal. (C) Cited2-null heart showing an abnormal L
(leftward) loop. (D-F) Right atrial isomerism is observed in Cited2-null embryos
with abnormal heart loops. Ventral views of hearts from 10.5 dpc show
expression of the MLC3F-nlacZ-2E transgene. (D) A Cited2 wild-type heart
shows a normal D (rightward) loop and asymmetric MLC3F-nlacZ-2E transgene.
(E) A Cited2-null heart shows a normal D loop and asymmetric MLC3F-nlacZ-
2E transgene. (F) A Cited2-null heart shows an L (leftward) loop and strong
bilateral expression of the MLC3F-nlacZ-2E transgene, indicating right atrial
isomerism. Arrows indicate orientation of the outflow tract. A, atrium; R L, right-
left axis. Scale bar: 100 µm.
Table 1. Genotype of mice resulting from Cited2
heterozygous intercross on a mixed C57BL6:129 genetic
background
Genotype
Stage Cited2+/+ Cited2+/– Cited2–/– P
8.5 dpc 68 184 100 0.0379
9.5 dpc 36 80 29 0.3283
10.5 dpc 36 84 31 0.3255
11.5 dpc 30 76 28 0.2897
12.5 dpc 14 23 10 0.7039
13.5 dpc 13 22 10 0.8097
14.5 dpc 106 159 85 (+6 dead) 0.0657
15.5 dpc 14 19 8 (+5 dead) 0.3724
16.5 dpc 5 12 8 (+1 dead) 0.6839
17.5 dpc 3 4 1 0.6065
PD21 402 615 0 <0.0001
Ratios of genotypes were tested for goodness of fit to expected Mendelian
segregation (1:2:1) by χ2 analysis, calculated with two degrees of freedom. P
value calculated at 14.5, 15.5 and 16.5 dpc for living embryos only. 
dpc, days post coitum; PD, postnatal day.
D
ev
el
op
m
en
t
1341Cited2 and heart morphogenesis
expression of Lefty1 in the PFP has not been previously
reported in laterality mutants; this demonstrates that Cited2
affects the establishment of laterality differently to any
known gene.
Pitx2c is initially expressed in the left LPM, and
then at later stages expression persists on the left side
of various LPM-derived tissues such as the sinus
venosus, common atrial chamber, cardinal vein,
vitelline vein, septum transversum and foregut
(Yoshioka et al., 1998). In all Cited2 wild-type (n=6)
and heterozygous (n=37) embryos examined, the
normal pattern of Pitx2c expression was observed in
the left LPM and later the left horn of the sinus venosus
(Fig. 3J,K). However, in four out of 12 Cited2-null
embryos, Pitx2c expression was entirely absent from
this left lateral mesoderm (Fig. 3L). This indicates that
Cited2 acts upstream of Pitx2c expression in lateral
mesoderm and is consistent with the fact that Pitx2c is
not expressed because of an absence of Nodal
expression in the lateral mesoderm.
In summary, one-third of Cited2-null embryos
showed loss of Nodal, Lefty2 and Pitx2c expression in
left LPM, and loss of Lefty1 expression in the anterior
PFP; this is consistent with the proportions of null
embryos, which had RAI (Table 2).
Pitx2c expression is Nodal responsive, its
expression relies on Foxh1-binding sites in the left
side-specific enhancer (ASE), and expression in the
heart requires its earlier expression in the lateral
mesoderm (Shiratori et al., 2001). Despite the fact that
Pitx2c expression in the heart has never been shown to
be uncoupled from its expression in the lateral
mesoderm, we examined Pitx2c expression in Cited2-
null hearts at 13.5 and 14.5 dpc to explore this
possibility. Pitx2c expression was readily detected in hearts
dissected from Cited2 wild-type (n=4), heterozygous (n=6) and
Fig. 3. Cited2-null embryos have abnormal expression of
left sided determinants. RNA in situ hybridization of
embryos and hearts hybridized with probes that recognize
Nodal (A-C), both Lefty1 and Lefty2 (D-I), and Pitx2 (J-R)
transcripts. Nodal is expressed in the left lateral mesoderm
(arrow) and node of six- to seven-somite stage Cited2 wild-
type (A) and heterozygous (B), but not in LPM of Cited2-
null (C) embryos. (D-I) A combined Lefty1/2 probe shows
that Lefty1 and Lefty2 are expressed in the left prospective
floor plate of the neural tube (white arrow), and left LPM
(black arrow) respectively, in seven- to nine-somite stage
Cited2-wild-type (D,G) and heterozygous (E,H) embryos. In
Cited2-null embryos (F,I), Lefty2 expression is not detected,
whereas the expression of Lefty1 is restricted to the
posterior floor plate. (J-L) Pitx2 is expressed in left lateral
mesoderm (arrow) of 12- to 14-somite stage Cited2 wild-
type (J) and heterozygous (K), but not Cited2-null (L)
embryos. (M-R) At 13.5 dpc, Pitx2 is expressed in the
ventral myocardium of the right ventricle, throughout the
left atrium and in ventrally viewed veins of Cited2 wild-type
embryos (M,P) and in null embryos that lack a laterality
defect (N,Q). Pitx2 is not expressed in the hearts of Cited2-
null embryos that have a right isomeric phenotype (O,R). In
some Cited2-null hearts, a novel domain of Pitx2 expression
was observed in dorsal ventricular cells (Q; arrow). Ventral
view (A-C,J-O), lateral view (D-F), posterior view (G-I),
dorsal view (P-R). Scale bar: 235 µm in A-C; 175 µm in D-
I; 365 µm in J-L; 335 µm in M-R.
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null (n=6) embryos that lacked laterality defects (Fig.
3M,N,P,Q; data not shown). By contrast, expression could not
be detected in the hearts of Cited2-null embryos with right
isomerism (n=7; Fig. 3O,R). Intriguingly, some Cited2-null
hearts displayed a novel expression domain on the dorsal
ventricular surface irrespective of their laterality phenotype
(n=4/13; Fig. 3Q; data not shown).
Cited2-null embryos develop a spectrum of severe
cardiovascular defects
Some cardiovascular defects that occur in Cited2-null embryos
have previously been reported (Bamforth et al., 2001; Yin et
al., 2002). Yet, the full spectrum of defects, their incidence and
association to one another has remained unexplored. As
Cited2-null embryos die late in gestation (Table 1) we
examined a total of 28 Cited2-null embryos on a mixed
C57Bl6;129 genetic background between 14.5 and 15.5 dpc
using high-resolution images obtained from EFIC and 3D
models (Weninger and Mohun, 2002). This revealed that
Cited2-null embryos showed a broad range of cardiac, vascular
and other defects, and were classified into four groups based
on the predominant cardiac defect (Table 2). The major defect
of group 1 embryos is right isomerism, the other abnormalities
being largely attributable to the patterning defects that
isomerism would impart. The incidence of isomerism in 14.5-
15.5 dpc hearts is consistent with our finding that ~40% of
embryos examined between 8.5 and 12.5 dpc have a laterality
defect. As embryos in groups 2 to 4 do not show isomerism,
the spectrum of cardiovascular defects they exhibit are likely
to result from other factors, such as the reduction of CNC cells,
or the lack of Cited2 expression in cardiac tissues.
Cardiovascular defects associated with right
isomerism
Nine out of 28 embryos (group 1; Table 2) demonstrated RPI
and RAI as a component of a complex cardiac phenotype
(compare Fig. 4A-C with 4D-F, Fig. 5A,C with 5B,D). Three-
dimensional reconstruction of these Cited2-null hearts shows
symmetrical arrangement of the atria, superior venae cavae and
pulmonary veins (Fig. 6; Fig. 7A,B). A single common atrium
is apparent with rudimentary ridges protruding into the lumen
from the dorsal side. Both atrial appendages resemble the
appearance of the normal right atrium (Figs 6-8). The superior
venae cavae and inferior vena cava, along with multiple small
mediastinal veins and a common pulmonary vein, drain into
the central atrial area, which is bordered by the rudimentary
ridges (Fig. 4B,G,H; Fig. 6C). In three embryos, an extra vessel
(possibly a persisting right umbilical vein) enters the central
atrial compartment from the caudal aspect (Fig. 6C′).
In six out of nine group 1 embryos, the common atrium was
connected to a single ventricle with the inflow tract of the
hypoplastic ventricle obstructed by the septal leaflet of a
common AV valve (Fig. 4G; Fig. 8A,B,D,D′). In three out of
nine group 1 embryos with an AV canal defect, there was a
large VSD immediately beneath the AV junction. As a result,
the common atrium opened equally into both ventricles (Fig.
4H). VSDs were apparent in three distinct sites: directly
beneath the origin of the great vessels (outflow), beneath the
AV junction (inflow) (Fig. 7C,C′; compare Fig. 4A,B with
4D,E, respectively), and near the apex cordis. Isomeric group
1 embryos also exhibited ventriculoarterial discordance and
aortic arch anomalies. The abnormal arrangement of the great
vessels and the ventricular chambers was manifest as either
transposition of the great arteries (TGA) or DORV (data not
shown). Aortic arch anomalies affected derivatives of the
fourth and sixth arch arteries, and included interrupted aortic
arch type B (IAA type B; Fig. 5, compare A and C with B and
D), aberrant (retro-esophageal) right subclavian artery (Fig.
4I), and abnormalities of the size and position of the ductus
arteriosus (data not shown).
In summary, nine out of 28 Cited2-null embryos examined
have a right isomeric pulmonary and cardiac phenotype in
combination with defects of the AV junction, ventricular
septum, outflow tract and aortic arches. Each lesion (except for
the muscular VSD) has previously been reported in association
with aberrant left-right embryonic patterning (see Maclean and
Dunwoodie, 2004; Schneider and Brueckner, 2000).
Cardiovascular defects in the absence of isomerism
Isomerism was not evident in the 15/28 Cited2-null embryos
(Table 2). Group 2 embryos exhibited similar defects as those
in group 1 but lack right isomerism. Group 3 defects were
restricted to outflow tract malformations (DORV, TGA and
overriding aorta) frequently in combination with muscular
VSDs. Three Cited2-null embryos had multiple VSDs only
(group 4), and a further four had a normal cardiac phenotype.
Endocardial cushions have reduced cell density in
Cited2-null hearts
Cited2 is expressed in myocardium adjacent to endocardial
cushions of the outflow tract and AV canal, and in some
endocardial and cushion cells (Fig. 1I,J,N,Q). In addition,
defects in endocardial cushions were detected at 14.5 dpc in
Cited2-null embryos (Fig. 4G; Fig. 8A,B,D,D′). Therefore, we
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Table 2. Phenotypic classification of Cited2-null embryos
Group 1 (n=9) Group 2 (n=4) Group 3 (n=8) Group 4 (n=3)
Right pulmonary isomerism 9
Right atrial isomerism 9
ASD 9, common atrium 4, foramen primum
AV junction 9, common AV canal 4, common AV canal, DILV
VSD 9, membranous, muscular 4, membranous, muscular 6, membranous, muscular 3, membranous, muscular
Outflow tract 9, DORV, TGA 4, DORV, PTA 8, DORV, TGA, OA
Pharyngeal arch arteries 9, RERSA, IAA type B 4, RERSA, IAA type B
A total of 28 embryos were analysed by EFIC and scored for phenotype of the cardiovascular system and lungs. Four embryos showed normal cardiovascular
and pulmonary structure and the remaining 24 were classified into four groups by severity of phenotype. ASD, atrial septal defect; AV, atrioventricular; VSD,
ventricular septal defects; DILV, double inlet left ventricle; DORV, double outlet left ventricle; TGA, transposition of the great arteries; PTA, persistent truncus
arteriousus; OA, overriding aorta; RERSA, retro-esophogeal right subclavian artery; IAA, interrupted aortic arch.
D
ev
el
op
m
en
t
1343Cited2 and heart morphogenesis
examined formation of endocardial cushions of
the AV canal at 10.5 dpc (Fig. 9). The average
cell density was significantly reduced
(P<0.0001) in Cited2-null hearts (1.8310–3
cells/µm2±0.1810–3) compared with that
in wild-type hearts (2.6810–3 cells/µm2±
0.1510–3) (compare Fig. 9E with 9F-H).
Furthermore, the area of the endocardial
cushions appeared to be reduced in the Cited2-
null hearts, this is despite the fact that the
overall sizes of the hearts compared were
comparable.
Discussion
Here, we present a description of the full spectrum of cardiac
defects that occur when the Cited2 gene is absent during
development. This analysis has revealed that right isomerism
is a feature of the Cited2-null phenotype, and thus has lead to
the finding that Cited2 is required for correct specification of
the left-right axis. In addition, the previously undefined
expression profile of Cited2, in the developing heart and in
tissues relevant to heart development, has been revealed.
Collectively, these data demonstrate that the spectrum of
cardiac defects is consistent with Cited2 functioning at a
number of levels to impact on heart development; these include
a role for Cited2 in establishment of the left-right axis, both
directly in cardiac tissue and, as previously suggested, in
cardiac neural crest cells.
A range of cardiac defects is observed in Cited2-null
embryos. This variability in expressivity/penetrance of the
phenotype is probably due to the effect(s) that polymorphism
of a modifier(s) has on Cited2 function. For example, the
incidence of right isomerism occurs in about 33% of Cited2-
null embryos with the 129/Olac;C57BL/6 genetic background
compared with about 50% when the mixed SJL;C57BL/6
genetic background of the MLC3F-nlacZ-2E transgene is
introduced.
Cited2 and the establishment of laterality
Establishment of left-right patterning can be divided into three
phases: an initial break in embryonic symmetry through cilia-
dependent processes originating in the node; establishment of
asymmetric gene expression in lateral mesoderm; and transfer
of positional information to developing organs. The Nodal
signaling pathway, which is central to this process in the lateral
mesoderm, is an important predictor of the phenotype
(Collignon et al., 1996; Lowe et al., 1996). For example, left-
sided expression results in situs solitus, right-sided expression
in situs inversus, bilateral expression in left isomerism and
absent expression in right isomerism.
The laterality defect in Cited2-null embryos is characterized
by right atrial and RPI (100% concordant), and 50% of these
individuals have altered abdominal situs. In addition, right
atrial isomerism always occurs where the heart is abnormally
looped. As Cited2 is expressed in and around the ventral node,
it is possible that Cited2 is required for cilia-dependent
processes or for the relay of the asymmetric signal to the lateral
mesoderm. Mutation in Dnah5, Dnah11/Lrd, Hfh4/Foxj1
results in immotile cilia of the node, random expression of
Nodal and the complete spectrum of laterality phenotypes:
situs solitus, situs inversus, left and right isomerism (Brody et
al., 2000; Chen et al., 1998; Collignon et al., 1996; Lowe et
al., 1996; Meno et al., 1996; Oh and Li, 2002; Olbrich et al.,
Fig. 4. Cited2-null embryos show a range of
pulmonary and cardiac defects. Two dimension
EFIC sections at 14.5 dpc through corresponding
planes of a Cited2-null embryo (A-C) and a wild
type (D-F) embryo. Cited2-null embryos show
symmetrical arrangement of lung lobes, similar
symmetry is evident in the size, topology and
branching of the left and right principal bronchus
(PB) and lobar bronchi (LB). Cited2-null embryos
show cardiac defects that include a ventricular septal
defect (arrows in A and B) and symmetrical right
and left atrial appendages (aa) adjoining a median
chamber (asterisk in B). Histological sections of
14.5 dpc Cited2-null embryos (G,H) show subtypes
of atrioventricular junction (J) malformations: (G)
single atrioventricular ostium opening solely into
the right ventricle, (H) single atrioventricular ostium
opening equally into both ventricles because of the
large ventricular septal defect. The median atrial
chamber is indicated by an asterisk. (I) Retro-
esophageal right subclavian artery (arrowhead). E,
esophagus; T, trachea; DA, descending aorta; VS,
ventricular septum; R, right; L, left. Scale bar: 500
µm in A-F; 500 µm in G-I.
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2002; Supp et al., 1999; Supp et al., 1997). Moreover,
mutations in genes that abrogate all nodal cilia (Kif3a, Kif3b,
polaris, Wim) or just the sensory cilia (polycistin 2) result in
absent, or bilateral Nodal expression that would result in situs
inversus and left isomerism (Huangfu et al., 2003; Marszalek
et al., 1999; Morgan et al., 1998; Moyer et al., 1994; Murcia
et al., 2000; Nonaka et al., 1998; Pennekamp et al., 2002;
Takeda et al., 1999; Wu et al., 2000). As Cited2-null embryos
exhibit only situs solitus or right isomerism, it is unlikely that
this gene is required only for cilia-dependent processes of the
node and the breaking of embryonic symmetry.
Consistent with Nodal acting as a left-sided determinant, we
have shown that complete absence of Nodal expression in
lateral mesoderm is predictive of the right isomeric phenotype
in Cited2-null embryos. This lack of Nodal suggests that
Cited2 is required for either the initiation or maintenance of
Nodal expression, and thus requires Cited2 to be expressed in
lateral mesoderm. Appropriately, we have demonstrated low-
level bilateral expression of Cited2 in mouse LPM and we
suggest that it acts in this tissue to initiate or maintain Nodal
expression.
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Fig. 5. Three-dimensional models of the bronchial system and great
arteries, illustrating the right isomeric phenotype of Cited2-null
embryos at 14.5 dpc. Models viewed from ventral (A,B) or left and
right sides (C,D). (A,A′) Differences in topology, size, course and
branching pattern of the right (yellow) and left (red) bronchial trees
in the normal embryo, as well as in the arrangement of the blood
vessels (brown). The Cited2-null embryo shows a symmetrical
bronchial tree (B,B′), profound differences in the relationship
between the bronchi and pulmonary arteries; transposition of the
great arteries and interruption of the aortic arch between the origin of
the left common carotid artery (CC) and the left subclavian artery
(SA). (B,D) The pulmonary trunk, pulmonary arteries, ductus
arteriosus, descending aorta, and left subclavian artery are shown in
magenta; the aorta, coronary arteries, brachiocephalic trunk, and left
common carotid artery are shown in gold. AA, ascending aorta; AR,
aortic arch; DA, descending aorta; PT, pulmonary trunk; PA,
pulmonary artery; DB, ductus arteriosus; CA, coronary artery; BT,
brachiocephalic trunk; T, trachea; LB, lobar bronchus.
Fig. 6. Three-dimensional models (A-C) and labeled diagrams (A′-C′)
showing atrial malformations of Cited2-null embryo hearts at 14.5
dpc. The models show the dorsal side of the atria (orange) and
associated blood vessels (blue). (A,A′) Normal, asymmetric atrial
appendages. (B,B′) Cited2-null hearts show symmetrical atrial
appendages, each resembling a normal right atrium. The left superior
vena cava (LSC) of the Cited2-null heart does not undercross the
common space formed by pulmonary veins (PV): the symmetric
arrangement of the pulmonary veins and the additional blood vessel
(asterisk) to the right of the inferior vena cava (IVC). (C,C′) Dorsal
atrial wall from the ventral aspect of a Cited2-null heart, after removal
of the ventricles and atrioventricular junction from the model.
Between the left and right atrial appendages, there is a median
chamber (MC, purple) that is incompletely separated from them by
ridges protruding from the dorsal side (arrowheads), this MC receives
all veins. RA, right atrial appendage; LA, left atrial appendage; RSC,
right superior vena cava; O, orifice of the lung vein.
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It is not clear how loss of Cited2 might affect Nodal
expression. Cited2 binds CBP/p300, Tfap2 and Lhx2/3, and
through its interaction with CBP/p300 affects the
transcriptional activity of Hif1 and Ets1 (Bamforth et al., 2001;
Braganca et al., 2002; De Guzman et al., 2004; Freedman et
al., 2003; Glenn and Maurer, 1999; Yahata et al., 2000; Yokota
et al., 2003). Investigation of the known Cited2-binding
proteins sheds no light on its function, as mutations in these
genes are not associated with laterality defects (Barton et al.,
1998; Goodman and Smolik, 2000; Iyer et al., 1998; Ryan et
al., 1998; Schorle et al., 1996; Shikama et al., 2003; Zhang et
al., 1996).
The expression of Lefty1 and Lefty2 is abnormal in a
proportion of Cited2-null embryos. Consistent with the loss of
Nodal expression in the left LPM, Lefty2 expression was not
detected. In addition, Lefty1 expression was largely not
detected in the left PFP as the loss of Nodal expression in
the left LPM might predict. Intriguingly, however, Lefty1
expression was readily detected in the posterior PFP.
Regulatory elements directing anterior and posterior
expression of Lefty1 and Lefty2 have been identified (Saijoh et
al., 1999), and so it is possible that Cited2, directly or
indirectly, acts through an enhancer that controls the anterior,
but not posterior, expression of Lefty1.
A proportion of Cited2-null embryos do not express Pitx2c
in left lateral mesoderm, or in right isomeric hearts at later
Fig. 7. Ventricular septal defects in Cited2-null embryos. (A) Three-
dimensional model of a 14.5 dpc Cited2-null heart, viewed from the
ventral side. (B) Ventral aspect, after removal of the ventral and
lateral walls of the ventricles, up to (but not including) the ventricular
septum (VS). The ventral and lateral walls of the atrial chambers
have also been removed. The right ventricle has only a small volume.
(C,C′) Model of (B) after 90° rotation (viewed from the left). A
ventricular septal defect (VSD) is evident beneath the outflow tract,
above the endocardardial cushion material (green, asterisk). A
second VSD can be seen beneath the free margin of the septal leaflet
(yellow) of the single atrioventricular valve. RA, right atrium; LA,
left atrium; RV, right ventricle; LV, left ventricle.
Fig. 8. Malformations in the atrioventricular junction of Cited2-null
embryos. (A) Semi-transparent view of a 14.5 dpc Cited2-null heart,
annotated in B. The cranial parts of the ventricles and atria have been
removed from the model. A single atrioventricular ostium opens
solely into the left ventricle (LV), guarded by leaflets (V) of a single
atrioventricular valve. (C) An equivalent view obtained by modeling
a normal heart. (D,D′) Atrioventricular junction of a Cited2-null
embryo, seen from the atrium after removal of the dorsal atrial wall.
The atrioventricular valve has only one leaflet (brown, asterisk) and
the opens into the left ventricle (arrowhead). (E,E′) Atrioventricular
junction of a Cited2-null heart, viewed from ventral side after
removal of the apical parts of the ventricle walls and the ventricle
septum (VS). The right (RV) and left (LV) ventricle differ in volume
and there is only a single opening of the atrioventricular ostium
(yellow, arrowhead) into the LV. LA, left atrium; RA, right atrium;
MC, median chamber of atrium; PV, pulmonary vein; LSC, left
superior vena cava; IVC, inferior vena cava; R L, right-left axis.
D
ev
el
op
m
en
t
1346
stages of development. This may simply reflect the fact that
Pitx2c expression requires Nodal signaling, and that Nodal is
not expressed in Cited2-null embryos with laterality defects.
This assumes that Pitx2c expression in the heart requires prior
expression of Pitx2c in the lateral mesoderm. No evidence
contradictory to this exists, and the fact that expression of
Pitx2c in the anterior lateral mesoderm at 8.5 dpc is consistent
with the sites of Pitx2c expression in the heart at later stages
(13.5-14.5 dpc) supports this hypothesis (Campione et al.,
2001). In addition, there are no cases in which Pitx2c
expression is observed in the heart in the absence of prior
expression in the anterior lateral mesoderm.
It is possible that Pitx2c expression in the heart has little to
do with prior gene activation by Nodal, and that Cited2 might
have a more direct role in its expression. This hypothesis is
supported by the overlapping expression patterns of Cited2 and
Pitx2c; both are expressed in the primary atrial septum,
pulmonary veins and superior vena cava. In addition, they are
expressed in the atrial myocardium, AV canals and outflow
tract, although Pitx2c is only expressed on the left side of these
structures (Campione et al., 2001; Franco and Campione, 2003;
Franco et al., 2000). Furthermore, embryos null for either
Cited2 or Pitx2c develop similar cardiac defects (Franco and
Campione, 2003; Liu et al., 2001).
A very recent report proposes that Cited2 acts directly
upstream of Pitx2c, and that the severe and complex heart
defects apparent in Cited2-null embryos, that lack a laterality
defect, occur because Cited2 is required to directly activate
Pitx2c expression in the heart (Bamforth et al., 2004). This
hypothesis seems unlikely for the following reasons. First,
Bamforth et al. (Bamforth et al., 2004) show that the activity
of the Pitx2c P1 promoter can be increased by about 1.5-fold
following co-transfection of Cited2 and the A and C isoforms
of transcription factor Tfap2 (in the hepatoma cell line Hep3B
cells). However, the degree of transactivation is slight in
comparison with a 25-fold increase in activation of the same
promoter fragment through the Nodal-responsive Fast1/Foxh1
binding sites (Shiratori et al., 2001). This suggests that if
Cited2-Tfap2a/c activates Pitx2c expression in the heart, it
does so at relatively low levels and thus is not a major
determinant of Pitx2c expression.
In addition, if the Cited2-Tfap2a/c complex activates Pitx2c
in the heart, one would expect in Cited2-null embryos where
laterality is normally established (and Pitx2c is expressed in
left lateral mesoderm) that Pitx2c expression would be greatly
reduced or absent in the heart. Evidence supporting this was
not provided by Bamforth et al. (Bamforth et al., 2004): three
Cited2-null hearts of a mixed genetic background (C57BL6/
J;129Sv) were examined for Pitx2c expression, one showed
reduced expression; however, the laterality status of these
hearts was not determined. By contrast, we find that Pitx2c
expression in the heart is coupled with its expression in lateral
mesoderm: Cited2-null embryos with right isomerism lack
Pitx2c expression in the left lateral mesoderm and in the heart;
those without a laterality defect express Pitx2c in both left
lateral mesoderm and the heart. Our data thus argues against
Cited2 playing a direct and major role in the expression of
Pitx2c in the heart, and instead supports the hypothesis that
loss of Pitx2c in the heart occurs only when this gene is not
expressed in the left lateral mesoderm at an earlier
developmental stage. Importantly, the Cited2-null embryos,
which express Pitx2c in the heart, still develop a complex array
of cardiac defects, indicating that Cited2 expression is required
in the heart for normal development and that it has Pitx2c-
independent functions.
Cited2, heterotaxia and congenital heart disease
Our studies of the Cited2-null phenotype in the mouse
demonstrate that mutation of a single gene can result in a
remarkably wide spectrum of cardiac malformations. To date,
no mutations have been identified in CITED2 in human
disorders; however, the right isomeric phenotype of Cited2-null
embryos resembles that seen in some individuals with
heterotaxia and, in particular, asplenia (Ivemark) syndrome
(OMIM 208530) (Ivemark, 1955). In humans, heterotaxia is a
clinically and genetically heterogeneous disorder that is
associated with a broad range of cardiac malformations. It
occurs in approximately one in 10,000 live born infants or 1%
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Fig. 9. Cited2-null embryos have reduced cell density of the atrioventricular cushions. Hematoxylin and Eosin-stained sections of Cited2 wild-
type (A,E) and null embryos (B-D,F-H) at 10 dpc. Sections were cut at a 45° angle (midway between frontal and transverse). (E-H) Higher
magnifications of the boxed regions in A-D, showing the reduced cell density within the atrioventricular cushions in the Cited2-null hearts.
Scale bar: 285 µm in A-D; 75 µm in E-H.
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of children with congenital heart disease, and common cardiac
manifestations are complex, including TGA, DORV or AV
septal defects (Hutchins et al., 1983; Rose et al., 1975;
Ruttenberg et al., 1964; Van Mierop and Wiglesworth, 1962).
Thus, the Cited2-null embryo provides a useful model with
which to investigating the etiology of heterotaxia in humans.
Furthermore, as the Cited2 mutation results in a spectrum of
phenotypes that vary widely in their severity, it raises the
possibility that many less severe congenital heart defects share
a common cause with each other and with heterotaxia.
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